[PDF] PHQ-9* Questionnaire for Depression Scoring and



Previous PDF Next PDF







GAD7 French for Canada

GAD-7 Au cours des 14 derniers jours, à quelle fréquence avez-vous été dérangé(e) par les problèmes suivants? (Utilisez un « 9 » pour indiquer votre réponse)



PHQ-9 & GAD-7

PHQ-9 & GAD-7 Over the last 2 weeks, on how many days have you been bothered by any of the following problems? Not at all Several Days More than half the days Nearly



PHQ-9 modified for Adolescents (PHQ-A)

7 Trouble concentrating on things like school work, reading, or watching TV? 8 Moving or speaking so slowly that other people could have noticed? Or the opposite – being so fidgety or restless that you were moving around a lot more than usual? 9 Thoughts that you would be better off dead, or of hurting yourself in some way?



Patient Health Questionnaire (PHQ-9)

How to Score the PHQ-9 Major depressive disorder (MDD) is suggested if: • Of the 9 items, 5 or more are checked as at least ‘more than half the days’



Administering and Scoring the PHQ-A Screening Questionnaire

Administering and Scoring the PHQ-A Screening Questionnaire Administering Patient checks in at the Reception desk Reception will present the PHQ-A (PHQ-9 modified for Adolescents) Questionnaire using the



PHQ 9: Depression Treatment Recommendations

PHQ‐9: Depression Treatment Recommendations The Patient Health Questionnaire (PHQ‐9) is a screening tool that provides an index of depression severity



Adverse Childhood Experiences International Questionnaire

Adverse Childhood Experiences International Questionnaire (ACE-IQ) D1 2 Section D: Guidance for Analysing ACE-IQ then that counts as a yes, and so that response should be circled, and a 1 placed in the



PHQ-9* Questionnaire for Depression Scoring and

23 UMHS Depression Guideline, August 2011 PHQ-9* Questionnaire for Depression Scoring and Interpretation Guide For physician use only Scoring:



Canadian Network for Mood and Anxiety - CMH

for 7 days, 20 mg/d for 7 days, then 40 mg/d if needed) is recommended to avoid adverse gastrointestinal effects 9 Vortioxetine, another multimodal antidepressant, acts as a serotonin reuptake inhibitor, an agonist at 5-HT 1A recep-tors, a partial agonist at 5-HT 1B receptors, and an antagonist at 5-HT 1D, 5-HT 3A, and 5-HT 7 receptors In 1

[PDF] echelle hamilton dépression

[PDF] la vision humaine

[PDF] questionnaire gad 7 francais

[PDF] la vision pdf

[PDF] la vision définition

[PDF] la vision spirituelle

[PDF] test hamilton pdf

[PDF] la vision de dieu

[PDF] limite vision humaine

[PDF] échelle d'anxiété de goldberg

[PDF] la vision d'une entreprise

[PDF] échelle de dépression de hamilton pdf

[PDF] la vision marvel

[PDF] échelle d'évaluation de l'anxiété préopératoire

[PDF] echelle de covi

23 UMHS Depression Guideline, August 2011

PHQ-9* Questionnaire for Depression Scoring and Interpretation Guide

For physician use only

Scoring:

Count the number (#) of boxes checked in a column. Multiply that number by the value indicated below, then add the subtotal to produce a total score. The possible range is 0-27. Use the table below to interpret the PHQ-9 score.

Not at all (#) _____ x 0 = _____

Several days (#) _____ x 1 = _____

More than half the days (#) _____ x 2 = _____

Nearly every day (#) _____ x 3 = _____

Total score: _____

Interpreting PHQ-9 Scores

Diagnosis

Total Score For Score Action

Minimal depression 0-4

Mild depression

5-9

Moderate depression 10-14

Moderately severe depression 15-19

Severe depression 20-27

5 - 14

> 14 The score suggests the patient may not need depression treatment Physician uses clinical judgment about treatment, based on patient's duration of symptoms and functional impairment Warrants treatment for depression, using antidepressant, psychotherapy and/or a combination of treatment. * The PHQ-9 is described in more detail at the Pfizer website: http://www.phqscreeners.com/quotesdbs_dbs13.pdfusesText_19